In the June edition of Pediatric Allergy, Immunology, and Pulmonology an article examines the underlying molecular mechanisms of asthma phenotypes and pays special attention to asthma endotypes and biomarkers. The article notes “a careful assessment of inflammatory endotypes should be considered a central component of the workup and management of severe asthma in children.” The biomarkers that have been identified for asthma “may help improve diagnosis and predict severity of the disease.” With further study into identifying biomarkers and endotypes, the authors suggest it could predict “major clinical outcomes and ultimately” lead “to personalized therapies.”
To view the full article, click here.
